Editorial - (2020) Volume 11, Issue 4
LONGDOM Journal of Diabetes & Metabolism has been started in the year 2010 and it released its first volume in the same year. Till now, the journal has released 10 volumes by the end of 2019 and is successfully running its 11th Volume.
The Journal of Diabetes & Metabolism is an open access publication that features scientific works of considerable significance and impact in all fields of Diabetes research such as: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Monogenic Diabetes, and cystic fibrosis-related diabetes, Latent autoimmune diabetes of adults (LADA), Diabetic Neuropathy, Diabetic Retinopathy, Diabetic Nephropathy, Diabetic hypoglycemia, and Obesity. The scope of the journal is not just restricted to Diabetes alone; works related to endocrinology, genetics, physiology, or cardio-vascular diseases which are loosely associated with Diabetes are equally welcome. It is a boon for researchers and students who wish to be kept abreast of the latest advancements in the field of Diabetes, it would help them build on the current know-how. Business people, policy makers, journalists, and practitioners can also benefit from the works published in the journal.
Classification of the Journal
1. Type 1 Diabetes
2. Type 2 Diabetes
3. Advances of Diabetes Cure
4. Childhood Diabetes
5. Hyperglycemia and Hypoglycemia
6. Diabetes and Alcohol
7. Diabetes and Weight Loss
8. Diabetes Cholestrol
9. Diabetes Lipid Metabolism
10. Diabetes Statistics
11. Latest Research on Diabetes
12. Obesity and Diabetes
13. Pathophysiology of Diabetes
The classification extends to the above and its related topics too.
During the year 2019, the Journal has released nearly 24 articles. During May, Longdom Group has acquired this journal from Omics group and from then on, all rights has been taken by the Longdom Group only.
Some of the articles released in 2019 are as follows:
1. A Comparative Study of Waist Hip Ratio and Body Mass Index (BMI) in Diabetic and Non Diabetic Individuals of Chitwan, Nepal.
2. A Prospective, Multicentre, Single Arm Clinical Study to Evaluate the Effect of Saroglitazar on Non High-Density Lipoprotein Cholesterol in Patients with Diabetic Dyslipidemia Inadequately Controlled with Diet, Exercise, and Statin-The GLIDDER Study.
3. Dysglycemia and Dyslipidemia Models in Nonhuman Primates: Part III. Type I or II Diabetogenic Effects of Streptozocin.
4. Assessment of 8-Hydroxy-2-Deoxyguanosine (8-OHdG) as a Diagnostic Marker for Diabetic Nephropathy in Type 1 Egyptian Diabetic Patients.
5. The Efficacy and Safety of Teneligliptin and Metformin versus Glimepiride and Metformin in Patients of Type-2 Diabetes Mellitus Uncontrolled with Monotherapy.
6. Dysglycemia and Dyslipidemia Models in Nonhuman Primates: Part IV. Pancreatic Beta Cell Dysfunction and Diabetes Progression.
7. The Potential of Combined Curcuma xanthorrhiza Rhizome and Averrhoa blimbi Fruit Extract on Decreasing Blood Glucose Levels, Insulitis Degree and Liver.
8. Structure Repair of Diabetic Male Wistar Rats Streptozotocin Induced.
9. Imeglimin: Therapeutic Option for Achieving Glycemic Control.
The journal has released the conference details relating to the journal in December 2019.
In the same way, the Journal expects to cover all the above classification topics for the year 2020 along with the present research in this field along with the current situation prevailing in globally i.e., COVID19.
Social media/digital marketing
The journal always was in contact with the scientific group of the world through its mails, social media networks and its digital platforms. Some of the best ways to be in contact with the audiences’ are:
1. Twitter postings: Regularly posting the articles, trends, updates of the journal. They can be visible at: @JDiabetesMetab.
2. Posting Google Analytics data in the website.
3. Using LinkedIn and Facebook for regular updates.
4. Regularly being in contact not only through mails but also through Whats App.
The complete details about the journal can be seen at:
https://www.longdom.org/diabetes-metabolism.html
For contacting us, mail us or Whats App us.
Lastly, Journal of Diabetes & Metabolism is nothing without the continuous support of the Editorial Board Members especially our Editor-in-Chief Hiroaki Satoh. The Editorial Board members are the back bone of the journal. Along with them, authors and reviewers play a very significant role in building this journal.
So, as an Editorial Co-ordinator I invite all the extended dignitaries in this field to submit their articles for bringing this research/expertise to the global scientific community.
Editor-in-Chief:
Hiroaki Satoh
Department of Metabolism and Endocrinology,
Graduate School of Medicine
Juntendo University, Japan
Editors:
Marta Di Carlo
Institute of Biomedicine and Molecular Immunology, Italy
Zhao-Qian Liu
Professor, Xiangya School of Medicine Central South University, China
Reviewers:
Jerzy Beltowski
Associate Professor, Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland
Sujatha Narayana Rao
Assistant Professor, Department of Biochemistry, AECS, Maruthi Dental College, Bengaluru, Karnataka, India., Bengaluru, India
Citation: Karunasree P (2020) Editorial-Journal of Diabetes & Metabolism. J Diabetes Metab 11:e102.
Received: 18-Apr-2020 Published: 28-Apr-2020, DOI: 10.35248/2155-6156.20.11.e102
Copyright: © 2020 Karunasree P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
